| 000 | 00816 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513004945.0 | ||
| 264 | 0 | _c19820322 | |
| 008 | 198203s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/ajp.139.1.132a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProcter, A W | |
| 245 | 0 | 0 |
_aCaffeine and benzodiazepine use. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cJan 1982 |
||
| 300 |
_a132 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBenzodiazepines _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCaffeine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aGreden, J F | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 139 _gno. 1 _gp. 132 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/ajp.139.1.132a _zAvailable from publisher's website |
| 999 |
_c7054898 _d7054898 |
||